2025-12-12
Tsinghua University Team Makes New Progress in Cross-Scale Biological Sample Cryopreservation
Cryopreservation technology, as a key support for cell therapy, regenerative medicine, organ transplantation, and biological resource preservation, has long been constrained by ice crystal damage—from single cells to complex organs, the formation, propagation, and recrystallization of ice during rewarming progressively amplify structural and functional damage. Recently, Assistant Professor Geng Hongya’s team at Tsinghua Shenzhen International Graduate School has achieved a breakthrough in cross-scale biological sample cryopreservation. The related findings were published in the top international journal Advanced Materials, offering innovative solutions to two core challenges: low-temperature ice inhibition and efficient rewarming.
2025-12-09
The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.
2025-11-28
This research represents a solid step toward this long-term goal at the scientific and technological foundation level. With the continuous iteration of related technologies, organ banks, once confined to science fiction, may become a reality, bringing hope to millions of patients worldwide awaiting organ transplants.
2025-11-28
A University of Virginia research team has pioneered a novel 3D-printable material compatible with the human immune system, as reported in the latest issue of Advanced Materials.
2025-11-21
Industry experts believe that this study marks a critical breakthrough for China in the field of tumor immunotherapy. It provides important insights for CAR-T therapy to tackle other solid tumors, such as lung and liver cancer, and will elevate China's level of tumor immunotherapy to new heights.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
